Frank Ruffo, Chief Financial Officer at Aclaris Therapeutics, Inc. (ACRS), sold 1,388 shares at $12.66 ($18K) on 2022-02-09, disclosed to the SEC on 2022-02-11.
Seasonal sale ($18k) by Chief Financial Officer — this insider has traded ACRS in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ACRS | SELL | 2021-04-26 | $3.0M | — | Filing → |
| ACRS | BUY | 2018-05-07 | $23K | — | Filing → |
| ACRS | BUY | 2018-04-09 | $21K | — | Filing → |